Found: 15
Select item for more details and to access through your institution.
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0302-9
- By:
- Publication type:
- Article
Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0305-6
- By:
- Publication type:
- Article
Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0300-y
- By:
- Publication type:
- Article
Prevalence of monoclonal gammopathy of undetermined significance in a large population with annual medical check-ups in China.
- Published in:
- 2020
- By:
- Publication type:
- Letter
DuoHexaBody-CD37<sup>®</sup>, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0292-7
- By:
- Publication type:
- Article
Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0304-7
- By:
- Publication type:
- Article
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0299-0
- By:
- Publication type:
- Article
Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0298-1
- By:
- Publication type:
- Article
Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma
- Published in:
- 2020
- By:
- Publication type:
- Letter
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0296-3
- By:
- Publication type:
- Article
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0295-4
- By:
- Publication type:
- Article
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A shared somatic translocation involving CUX1 in monozygotic twins as an early driver of AMKL in Down syndrome.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment.
- Published in:
- 2020
- By:
- Publication type:
- Letter